KR101324920B1 - 개선된 생체적합성을 갖는 카르니틴-함유 복막 투석 용액 - Google Patents

개선된 생체적합성을 갖는 카르니틴-함유 복막 투석 용액 Download PDF

Info

Publication number
KR101324920B1
KR101324920B1 KR1020077023099A KR20077023099A KR101324920B1 KR 101324920 B1 KR101324920 B1 KR 101324920B1 KR 1020077023099 A KR1020077023099 A KR 1020077023099A KR 20077023099 A KR20077023099 A KR 20077023099A KR 101324920 B1 KR101324920 B1 KR 101324920B1
Authority
KR
South Korea
Prior art keywords
carnitine
glucose
peritoneal dialysis
solution
delete delete
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1020077023099A
Other languages
English (en)
Korean (ko)
Other versions
KR20070116630A (ko
Inventor
아르두이노 아르두이니
Original Assignee
씨그마-토 인더스트리에 파마슈티체 리유니테 에스. 피. 에이.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 씨그마-토 인더스트리에 파마슈티체 리유니테 에스. 피. 에이. filed Critical 씨그마-토 인더스트리에 파마슈티체 리유니테 에스. 피. 에이.
Publication of KR20070116630A publication Critical patent/KR20070116630A/ko
Application granted granted Critical
Publication of KR101324920B1 publication Critical patent/KR101324920B1/ko
Assigned to 코어퀘스트 에스에이지엘 reassignment 코어퀘스트 에스에이지엘 권리의 전부이전등록 Assignors: 알파시그마 에스.피.에이.
Assigned to 알파시그마 에스.피.에이. reassignment 알파시그마 에스.피.에이. 권리의 전부이전등록 Assignors: 씨그마-토 인더스트리에 파마슈티체 리유니테 에스. 피. 에이.
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/20—Elemental chlorine; Inorganic compounds releasing chlorine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • External Artificial Organs (AREA)
KR1020077023099A 2005-03-10 2006-02-22 개선된 생체적합성을 갖는 카르니틴-함유 복막 투석 용액 Expired - Fee Related KR101324920B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITPCT/IT2005/000130 2005-03-10
IT2005000130 2005-03-10
PCT/EP2006/060162 WO2006094900A1 (en) 2005-03-10 2006-02-22 Carnitine-containing peritoneal dialysis solution having improved biocompatibility

Publications (2)

Publication Number Publication Date
KR20070116630A KR20070116630A (ko) 2007-12-10
KR101324920B1 true KR101324920B1 (ko) 2013-11-01

Family

ID=35159907

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020077023099A Expired - Fee Related KR101324920B1 (ko) 2005-03-10 2006-02-22 개선된 생체적합성을 갖는 카르니틴-함유 복막 투석 용액

Country Status (19)

Country Link
US (1) US20080138443A1 (cg-RX-API-DMAC10.html)
EP (1) EP1858504B1 (cg-RX-API-DMAC10.html)
JP (2) JP4717110B2 (cg-RX-API-DMAC10.html)
KR (1) KR101324920B1 (cg-RX-API-DMAC10.html)
AR (1) AR054015A1 (cg-RX-API-DMAC10.html)
AT (1) ATE539742T1 (cg-RX-API-DMAC10.html)
CA (1) CA2599252C (cg-RX-API-DMAC10.html)
CY (1) CY1112794T1 (cg-RX-API-DMAC10.html)
DK (1) DK1858504T3 (cg-RX-API-DMAC10.html)
ES (1) ES2380168T3 (cg-RX-API-DMAC10.html)
HR (1) HRP20120177T1 (cg-RX-API-DMAC10.html)
ME (1) ME02948B (cg-RX-API-DMAC10.html)
MX (1) MX2007010814A (cg-RX-API-DMAC10.html)
PL (1) PL1858504T3 (cg-RX-API-DMAC10.html)
PT (1) PT1858504E (cg-RX-API-DMAC10.html)
RS (1) RS52237B (cg-RX-API-DMAC10.html)
SI (1) SI1858504T1 (cg-RX-API-DMAC10.html)
TW (1) TWI388318B (cg-RX-API-DMAC10.html)
WO (1) WO2006094900A1 (cg-RX-API-DMAC10.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2365429B1 (es) * 2010-03-05 2012-09-06 Universidad De Castilla De La Mancha Solucion para dialisis peritoneal
WO2018031922A1 (en) * 2016-08-11 2018-02-15 Sulfilatec, Inc. Medical and nutritional compositions and methods of use
ES2750642A1 (es) * 2018-09-26 2020-03-26 Univ Vigo Composición farmacéutica que comprende proteína amiloide P de suero para tratar la insuficiencia renal aguda o crónica
EP3912656A1 (en) 2020-05-19 2021-11-24 CoreQuest Sagl Peritoneal dialysis solution

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040014961A1 (en) * 2002-06-06 2004-01-22 Daniel Backer Soluble highly branched glucose polymers and their method of production
US6822002B1 (en) * 1999-10-11 2004-11-23 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Use of L-carnitine and its alkanoyl derivatives as osmotic agents in solutions for medical use

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5126373A (en) 1987-11-19 1992-06-30 Henri Brunengraber Composition for parenteral and oral nutrition
JPH08131542A (ja) * 1994-11-11 1996-05-28 Baxter Kk 腹膜透析液調製用溶液セット
CA2155910C (en) 1995-08-11 1999-12-14 George Wu Biocompatible aqueous solution for use in continuous ambulatory peritoneal dialysis
GB9714218D0 (en) * 1997-07-04 1997-09-10 Allied Therapeutics Ltd Peritoneal dialysis fluid
EP1009452A4 (en) * 1997-08-07 2004-03-31 Ajay Gupta WATER-SOLUBLE VITAMINS AND DIALYSIS SOLUTION CONTAINING NUTRIENTS
DE19748290B8 (de) 1997-10-31 2009-09-03 Fresenius Medical Care Deutschland Gmbh Lösung für die Peritonealdialyse
JP2002282354A (ja) 2001-03-27 2002-10-02 Jms Co Ltd 腹膜透析液
GB0108359D0 (en) * 2001-04-03 2001-05-23 Allied Therapeutics Ltd Peritoneal dialysis fluid
ITRM20010337A1 (it) * 2001-06-14 2002-12-16 Sigma Tau Ind Farmaceuti Soluzione per la conservazione e perfuzione di organi in attesa che vengano trapiantati.
JP2004016615A (ja) * 2002-06-19 2004-01-22 Fuso Pharmaceutical Industries Ltd 晶質浸透圧剤及び膠質浸透圧剤を含有する腹膜透析液
US20060046975A1 (en) 2002-12-10 2006-03-02 Ola Carlsson Method for preparing a medical solution for the manufacture of a medicament for peritoneal dialysis
JP2006075195A (ja) * 2004-09-07 2006-03-23 Jms Co Ltd Ｌカルニチン含有腹膜透析液

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6822002B1 (en) * 1999-10-11 2004-11-23 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Use of L-carnitine and its alkanoyl derivatives as osmotic agents in solutions for medical use
US20040014961A1 (en) * 2002-06-06 2004-01-22 Daniel Backer Soluble highly branched glucose polymers and their method of production

Also Published As

Publication number Publication date
TWI388318B (zh) 2013-03-11
EP1858504A1 (en) 2007-11-28
EP1858504B1 (en) 2012-01-04
KR20070116630A (ko) 2007-12-10
JP5366894B2 (ja) 2013-12-11
DK1858504T3 (da) 2012-04-30
US20080138443A1 (en) 2008-06-12
PL1858504T3 (pl) 2012-05-31
TW200714279A (en) 2007-04-16
ATE539742T1 (de) 2012-01-15
CA2599252A1 (en) 2006-09-14
PT1858504E (pt) 2012-04-10
HRP20120177T1 (hr) 2012-03-31
AR054015A1 (es) 2007-05-30
CY1112794T1 (el) 2016-02-10
CA2599252C (en) 2013-07-30
RS52237B (sr) 2012-10-31
JP2008532601A (ja) 2008-08-21
ME02948B (me) 2012-10-31
JP4717110B2 (ja) 2011-07-06
WO2006094900A1 (en) 2006-09-14
SI1858504T1 (sl) 2012-04-30
ES2380168T3 (es) 2012-05-09
MX2007010814A (es) 2007-11-07
JP2010207630A (ja) 2010-09-24

Similar Documents

Publication Publication Date Title
US6180139B1 (en) Composition and method for treating nonalcoholic steatohepatitis
JPS62265232A (ja) 脂質置換治療法
KR20200039748A (ko) 간 질환 치료를 위한 아미노산 조성물
US20090269369A1 (en) Ophthalmic Composition Comprising Xanthan Gum and Glucose
EA025137B1 (ru) Раствор для диализа, включающий одно или более соединений креатина и способ его получения
US8129430B2 (en) Method of reducing phosphate nephropathy in a mammal
EA013846B1 (ru) Фармацевтическая композиция, содержащая лактат, и ее применение
US9402818B2 (en) Use of amides of mono- and dicarboxylic acids in the treatment of renal diseases
CN110327367A (zh) 含有硝酸盐和维生素的组合物、其制备方法、制剂及其用途
WO2013151341A1 (en) Injectable composition comprising phosphatidylcholine and method for preparing thereof
JP5366894B2 (ja) 生体適合性が改善されたカルニチンを含有する腹膜透析液
HU220214B (hu) Eljárás patológiás bél-permeabilitás és legyengült immunfunkciók kezelésére alkalmas, glutamintartalmú gyógyszerkészítmények előállítására
US20030021858A1 (en) Formulation and method for treating skeletal muscle degeneration caused by malnutrition and disease
Clode et al. A stage‐dependent effect of ethanol on 9.5‐day rat embryos grown in culture and the role played by the concomitant rise in osmolality
ITRM990483A1 (it) Composizione per la prevenzione e cura delle disfunzioni e patologie renali di tipo tossico e funzionale.
TW201500042A (zh) 與血液透析有關的低血壓的治療
US7033612B2 (en) Composition and method for treating age-related disorders
US20250099415A1 (en) Methods for Inhibiting the Progression of Oxidative Retinal Disease
JPH085791B2 (ja) 抗白内障剤
AU2017306756A1 (en) Glutamine for preserving, improving or restoring kidney function
KR101751533B1 (ko) 포스파티딜콜린 및 바이페닐-디메틸-디카르복실레이트를 포함하는 간 질환 예방 또는 치료용 조성물
US20070197593A1 (en) Hydroxylamines and derivatives for treatment of inflammatory conditions of the liver
Nordstrand et al. Mortality and organ changes in rats receiving different parenteral nutritional substrates
JP3756449B2 (ja) 抗潰瘍剤、抗潰瘍剤の製造方法、α−ラクトアルブミンの使用、及び潰瘍の治療方法
WO2024023312A1 (en) Catechin containing formulations for use in treating diabetic cardiomyopathy

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

FPAY Annual fee payment

Payment date: 20161014

Year of fee payment: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

FPAY Annual fee payment

Payment date: 20171017

Year of fee payment: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

FPAY Annual fee payment

Payment date: 20181023

Year of fee payment: 6

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R11-asn-PN2301

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R14-asn-PN2301

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R14-asn-PN2301

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 7

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 8

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 9

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 10

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 11

PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20241029

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

H13 Ip right lapsed

Free format text: ST27 STATUS EVENT CODE: N-4-6-H10-H13-OTH-PC1903 (AS PROVIDED BY THE NATIONAL OFFICE); TERMINATION CATEGORY : DEFAULT_OF_REGISTRATION_FEE

Effective date: 20241029

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20241029